Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival

BACKGROUND: Interleukin(IL)-30/IL-27p28 production by Prostate Cancer (PC) Stem-Like Cells (SLCs) has proven, in murine models, to be critical to tumor onset and progression. In PC patients, IL-30 expression by leukocytes infiltrating PC and draining lymph nodes correlates with advanced disease grad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrentino, Carlo, Yin, Zhinan, Ciummo, Stefania, Lanuti, Paola, Lu, Li-Fan, Marchisio, Marco, Bellone, Matteo, Di Carlo, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670138/
https://www.ncbi.nlm.nih.gov/pubmed/31366386
http://dx.doi.org/10.1186/s40425-019-0668-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670138/
https://www.ncbi.nlm.nih.gov/pubmed/31366386
http://dx.doi.org/10.1186/s40425-019-0668-z

Ejemplares similares